John Paul Johnson - 01 Jul 2025 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
01 Jul 2025
Transactions value $
$0
Form type
4
Filing time
03 Jul 2025, 07:06:18 UTC
Previous filing
04 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson John Paul Chief Financial Officer C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON /s/ Jonathan Weinberg, Attorney-in-fact 03 Jul 2025 0001782040

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +25.5K +8.97% $0.00 309K 01 Jul 2025 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028.
F3 Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting.
F4 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.